TY - JOUR
T1 - Spontaneous in vitro transformation of primary human osteoblast-like cells
AU - Magdolen, Ursula
AU - Schmitt, Manfred
AU - Hildebrandt, Barbara
AU - Diehl, Peter
AU - Schauwecker, Johannes
AU - Saldamli, Belma
AU - Burgkart, Rainer
AU - Tübel, Jutta
AU - Gradinger, Rainer
AU - Royer-Pokora, Brigitte
PY - 2010
Y1 - 2010
N2 - Background: Two new tumor-like cell lines were established which developed spontaneously in vitro from normal human primary osteoblast-like cells originating from non-oncogenic bone surgery. Materials and Methods: The tumor cell properties studied included morphology, proliferation characteristics in normal and low-serum media, and anchorage-independent growth in soft agarose. Results and Conclusion: Karyotyping of the cells showed numerous rearrangements and abnormalities. These results pointed to the tumorigenic potential of the cells and demonstrate the importance of biosafety in tissue engineering and therapeutic cell applications when prolonged culture conditions are required.
AB - Background: Two new tumor-like cell lines were established which developed spontaneously in vitro from normal human primary osteoblast-like cells originating from non-oncogenic bone surgery. Materials and Methods: The tumor cell properties studied included morphology, proliferation characteristics in normal and low-serum media, and anchorage-independent growth in soft agarose. Results and Conclusion: Karyotyping of the cells showed numerous rearrangements and abnormalities. These results pointed to the tumorigenic potential of the cells and demonstrate the importance of biosafety in tissue engineering and therapeutic cell applications when prolonged culture conditions are required.
KW - Biosafety
KW - Chromosome rearrangement
KW - Immortalization
KW - Primary human osteoblast-like cells
UR - http://www.scopus.com/inward/record.url?scp=77950940528&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:77950940528
SN - 1109-6535
VL - 7
SP - 61
EP - 66
JO - Cancer Genomics and Proteomics
JF - Cancer Genomics and Proteomics
IS - 2
ER -